# Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline

> **NCT05984186** · NA · COMPLETED · sponsor: **Vapotherm, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Dyspnea
- Lactic Acidosis
- Muscle
- Breathlessness
- Exercise
- Recovery

## Interventions

- **DEVICE:** High Velocity Therapy

## Key facts

- **NCT ID:** NCT05984186
- **Lead sponsor:** Vapotherm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-06
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05984186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05984186, "Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05984186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*